Adawi Kamal 4
4 · EXAGEN INC. · Filed Feb 10, 2023
Insider Transaction Report
Form 4
EXAGEN INC.XGN
Adawi Kamal
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-08$2.69/sh−5,821$15,671→ 91,938 total
Footnotes (1)
- [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.